Latest Breaking News On - Capital holdings plc - Page 15 : comparemela.com

RWA Wealth Partners LLC Invests $217,000 in Zscaler, Inc (NASDAQ:ZS)

RWA Wealth Partners LLC bought a new position in Zscaler, Inc. (NASDAQ:ZS – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 981 shares of the company’s stock, valued at approximately $217,000. Several other hedge funds also recently made changes […]

Jagtar singh chaudhryDekabank deutsche girozentraleRemo canessaPolar capital holdings plcRwa wealth partnersZscaler incVanguard group incHermes incInternational assets investment managementExchange commissionCantor fitzgeraldNeedham companyFree reportCapital holdings plcAssets investment managementBank deutsche girozentrale

Bailard Inc Acquires 630 Shares of Rambus Inc (NASDAQ:RMBS)

Bailard Inc. grew its holdings in Rambus Inc. (NASDAQ:RMBS – Free Report) by 3.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,785 shares of the semiconductor company’s stock after acquiring an additional 630 shares during the quarter. Bailard Inc.’s holdings in Rambus were […]

South koreaUnited statesLuc seraphinBailard incNorthern trust corpRambus incYork mellon corpPolar capital holdings plcAmeriprise financial incRambus company profileJpmorgan chase coWells fargo companyExchange commissionFree reportNew york mellon corpTrust corp

Blueprint Medicines (NASDAQ:BPMC) Earns Buy Rating from HC Wainwright

Blueprint Medicines (NASDAQ:BPMC) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesChristopherk murrayStifel nicolausMichael landsittelPolar capital holdings plcNeedham companySecurities exchange commissionBlueprint medicines corporationNorges bankBlueprint medicinesGet free reportMedicines stock downExchange commissionCapital holdings plcSprings capital managementPartners management

Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Raised to $36 00 at JPMorgan Chase & Co

Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Raised to $36 00 at JPMorgan Chase & Co
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerJeremy benderDay one biopharmaceuticals incFranklin resources incVanguard group incDay one biopharmaceuticals company profileGoldman sachs group incPolar capital holdings plcJpmorgan chase coGoldman sachs groupDay one biopharmaceuticalsFree reportModerate buyOne biopharmaceuticalsGet free reportDay one

New York State Common Retirement Fund Boosts Position in RenaissanceRe Holdings Ltd (NYSE:RNR)

New York State Common Retirement Fund Boosts Position in RenaissanceRe Holdings Ltd (NYSE:RNR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesDavide marraCarolp sandersYork state common retirement fundRenaissancere holdings ltdVanguard group incPolar capital holdings plcSecurities exchange commissionYork mellon corpJpmorgan chase coNew york state common retirement fundRenaissancere holdingsFree reportNew york mellon corpCapital holdings plc